Valuation: Solventum Corporation

Market Cap 14.72B 12.76B 11.96B 10.9B 20.52B 1,405B 20.85B 141B 54.97B 703B 55.25B 54.06B 2,346B P/E 2026 *
47.9x
P/E 2027 * 24.6x
Enterprise Value 20B 17.33B 16.25B 14.81B 27.87B 1,908B 28.32B 191B 74.69B 955B 75.07B 73.44B 3,187B EV / Sales 2026 *
2.43x
EV / Sales 2027 * 2.31x
Free-Float
82.37%
Yield 2026 *
-
Yield 2027 * -
1 day+0.12%
1 week+4.22%
Current month+1.19%
1 month+11.68%
3 months+16.19%
6 months+14.44%
Current year+9.11%
1 week 81.76
Extreme 81.76
86.81
1 month 75.69
Extreme 75.69
90
Current year 62.38
Extreme 62.38
90
1 year 62.38
Extreme 62.38
90
3 years 47.16
Extreme 47.16
96.05
5 years 47.16
Extreme 47.16
96.05
10 years 47.16
Extreme 47.16
96.05
Date Insider Type Main position Quantity % Market Cap.
4/30/26 Fiscal year

Chairman

9,832 0.0057%
3/27/26 Fiscal year

Chairman

12,672 0.0073%
3/5/26 Fiscal year

Chief Financial Officer

55,711 0.0321%
Change 5-day change 1-year change 3-year change Capi.($)
+0.11%+4.22%+16.24% - 14.72B
-0.14%+3.07%-14.01%+5.66% 193B
+0.29%+5.42%-2.51%+8.54% 116B
-1.07%-4.62%+6.52%+65.45% 59.16B
+0.32%+3.92%+38.42%+65.14% 55.75B
-0.24%+2.77%-7.14%-35.54% 49.57B
-0.39%+10.19%+14.41%-18.09% 34.52B
+0.53%+3.10% - - 31.22B
-0.24%-0.70%+40.59%-12.31% 24.36B
+1.98%+12.62%-2.80%+25.91% 24.25B
Average +0.02%+4.10%+9.97%+13.10% 60.2B
Weighted average by Cap. -0.13%+3.55%+1.48%+13.53%

Financials

2026 *2027 *
Net sales 8.23B 7.13B 6.69B 6.1B 11.47B 785B 11.65B 78.72B 30.73B 393B 30.89B 30.22B 1,311B 8.51B 7.38B 6.92B 6.31B 11.87B 812B 12.06B 81.45B 31.8B 407B 31.96B 31.27B 1,357B
Net income 318M 276M 259M 236M 444M 30.39B 451M 3.05B 1.19B 15.21B 1.2B 1.17B 50.74B 601M 521M 489M 446M 839M 57.41B 852M 5.75B 2.25B 28.74B 2.26B 2.21B 95.86B
Net Debt 5.28B 4.57B 4.29B 3.91B 7.36B 504B 7.48B 50.5B 19.71B 252B 19.81B 19.39B 841B 4.95B 4.29B 4.02B 3.67B 6.9B 472B 7.01B 47.36B 18.49B 236B 18.58B 18.18B 789B
Logo Solventum Corporation
Solventum Corporation specializes in the marketing of tools used in the medical field. Net sales break down by family of products as follows: - medical instruments and accessories (56.2%): for wound care, sterilization, surgery, etc.; - medical information systems (15.8%): including software solutions for documentation, billing, coding, data visualization, etc. in hospital environments; - dental and orthodontic instruments and accessories (15.7%): for dental care and restoration; - purification and filtration instruments (11.6%): used in the medical, bio-pharmaceutical, agri-food and other sectors; - other (0.7%). The United States accounts for 57.5% of net sales.
Employees
20,584
Date Price Change Volume
26-08-13 US$86.46 +1.37% 1,232,089
26-08-12 US$85.29 +1.41% 833,980
26-08-11 US$84.10 -1.30% 773,865
26-08-10 US$85.21 +2.69% 1,400,390
26-08-07 US$82.98 +0.02% 1,104,147
Trader
Investor
Global
Quality
ESG MSCI
BBB
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
15
Last Close Price
86.46USD
Average target price
93.92USD
Spread / Average Target
+8.63%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. SOLV Stock